| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | malioxamycin Basic information |
| Product Name: | malioxamycin | | Synonyms: | malioxamycin;(R)-[[[(S)-2-Amino-3-methyl-1-oxobutyl]amino]oxy]butanedioic acid;KXQRAPMNPUXYGT-VDTYLAMSSA-N;Butanedioic acid, [[[(2S)-2-amino-3-methyl-1-oxobutyl]amino]oxy]-, (2R)- (9CI) | | CAS: | 73020-27-6 | | MF: | C9H16N2O6 | | MW: | 248.23 | | EINECS: | | | Product Categories: | | | Mol File: | 73020-27-6.mol |  |
| | malioxamycin Chemical Properties |
| density | 1.353±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 10 mg/ml | | form | A crystalline solid | | pka | 3.19±0.23(Predicted) |
| | malioxamycin Usage And Synthesis |
| Description | Malioxamycin is an antibiotic with spheroplast-forming activity. It is formed from a valine and amino group attached to a malic acid moiety. | | Uses | Malioxamycin is an antibiotic that inhibits Gram-negative bacteria by inhibiting peptidoglycan synthesis in bacterial cell walls and promoting the formation of spheroplasts[1]. | | Definition | ChEBI: Malioxamycin is a valine derivative. | | References | [1] S Takahashi, et al. Malioxamycin, a new antibiotic with spheroplast-forming activity. II. Structural elucidation and total synthesis. J Antibiot (Tokyo). 1980 Nov;33(11):1220-3. |
| | malioxamycin Preparation Products And Raw materials |
|